Analysis of national health prevention programs based on implemented actions aimed at reducing tobacco use in Poland
-
Copyright
© 2022 PRO MEDICINA Foundation, Published by PRO MEDICINA Foundation
User License
The journal provides published content under the terms of the Creative Commons 4.0 Attribution-International Non-Commercial Use (CC BY-NC 4.0) license.
Authors
Objective
The aim of this study is to
compare selected national health prevention programs regarding their proposed
actions aimed to reduce the use of tobacco products in Poland and to assess
their performance indicators.
Methods
Twelve national health
prevention programs coordinated by the Ministry of Health were analyzed, all
relating to the reduction of tobacco use. We analyzed the websites and
publications by the Ministry of Health and the subordinate agencies responsible
for the implementation of each program.
Three programs were selected
for the final analysis:
·
the Prevention of tobacco-related disorders program (including
COPD);
·
the National Oncology Strategy,
·
the National Health Program.
Results
The public administration
agency responsible for the implementation of public national anti-smoking
prevention programs in Poland is the Ministry of Health. The legal basis for
the operation of the national campaigns is usually the regulations of the
Council of Ministers. In the three analyzed programs, the proposed strategic
objectives for anti-smoking prevention may be considered the same. The programs
are primarily focused on providing counseling to smokers and training medical
staff on how to support patients in their efforts to quit smoking.
Conclusions
The lack of a single
comprehensive anti-smoking program leads to proposed actions being reiterated
several times. There is currently no institution that coordinates anti-smoking
actions. Because anti-smoking measures are multidisciplinary, it is difficult
to identify the direct impact of a single health program on i.e. reduced incidence
of tobacco-related disorders. It is, therefore, appropriate to maintain the
overall performance indicators without setting specific targets.
Introduction
The World Health Organization
states that the tobacco smoking epidemic remains the largest international
public health challenge killing more than 8 million people annually, including
1.2 million deaths from passive smoking [1].
In Poland, it is estimated
that tobacco is used by 26% of adult Poles (32% of men and 20% of women) every
day, and so Poland ranks 12th in the European Union. Most smokers are found in
Greece - 42%, followed by Bulgaria - 38% and Croatia - 36%, while the least
smokers are in Sweden - 7%, the Netherlands - 12%, and Finland - 15%. The
anti-smoking activities in Poland in recent years may be considered effective
since the number of people using tobacco products decreased by 9% compared to
2006 [2].
The current research suggests
that exposure to tobacco smoke contributes to many disorders (including lung
disorders and myocardial infarction, chronic pulmonary disease, cancer, and
diabetes). At the same time, considering the COVID-19 epidemic which may
exacerbate those diseases, promotion of smoking cessation seems even more
important [3]. All the more so that the vast majority of smokers in Poland
declare that knowing the negative impact of COVID-19 on the respiratory system
did not lead to them reducing their nicotine consumption. The youngest smokers
are particularly discernible here, who generally declare no limitations in that
respect [4].
Taking all of this into
account, it is important to implement educational programs aimed at raising
awareness among Poles about the consequences of tobacco smoking. Since 1997,
the activities carried out at the central level have been included in the Program for Prevention of Health
Consequences of Smoking in Poland published by the Council of Ministers
based on Article 4 of the Act on health prevention against consequences of
tobacco and tobacco product use of November 9th, 1995 (Journal of Laws of 2021, item 276) [5].
Since 2007, under the authority of the Minister of Health, the
implementation, and coordination of this program was the responsibility of the
Chief Health Officer. Due to the interpretation issues of Article 4 of the Act
regarding the financing of the program, while working on the Public Health Act
[6], it was decided to repeal Article 4 and to include actions to limit smoking
of tobacco products in the National Health Program from 2018 onwards.
Recently, at the national
level, actions have also been taken for primary prevention and detection of
selected tobacco-related disorders (such as the Prevention of chronic
obstructive pulmonary disease “Take a deep breath” program [7], the Polish
national cerebrovascular disease prevention program (ICD10: I60-I69) [8], the
Prevention and treatment of cardiovascular diseases program POLKARD [9] or the
National Oncology Strategy [10]).
Due to a large number of anti-smoking
programs implemented in Poland, it seems appropriate to carry out an analysis
of whether the selected programs do not duplicate the same proposals for action
and whether the proposed indicators for their implementation adequately assess their
effectiveness.
Materials
and Methods
This study is a retrospective
analysis of data on national health prevention programs for tobacco-related
disorders implemented in Poland between 2016 and 2022. We analyzed the national
health prevention programs coordinated by the Ministry of Health between 2016
and 2022. Based on the data available on the official websites of the Ministry
of Health and the National Health Fund, including the Public Information
Bulletin of the Ministry of Health, twelve national health prevention programs
were identified coordinated by the Ministry of Health relating to tobacco use
reduction (Table 1). The objectives of each program were analyzed, emphasizing
the type of intervention and the target group. The scope of the programs usually
covered prevention and early diagnosis of selected tobacco-related disorders
(cancer, COPD, stroke, heart disease, type 2 diabetes). For 9 out of the 12
programs, the anti-smoking measures were considered a secondary objective
without any specific and targeted anti-smoking interventions. Three programs
were included in the final analysis, which covered anti-smoking actions as one
of their main objectives.
The following programs were
analyzed in detail:
·
the Prevention of tobacco-related disorders program (including
COPD);
·
the National Oncology Strategy;
·
the National Health Program.
The detailed analysis included
the publications by the Ministry of Health and the subordinate agencies responsible
for the implementation of each program. During the analysis, we compared the
strategic objectives regarding tobacco, the proposed target groups, the planned
actions, and the performance indicators.
A detailed analysis of those
programs was conducted as they all include comprehensive preventive measures
while identifying the precise tasks involved in reducing tobacco consumption.
In addition, the prevention program for tobacco-related disorders (including
COPD) is currently the only program dedicated entirely to smoking reduction.
Moreover, on July 7th, 2022, the National Oncology Strategy was
significantly amended.
Since 1997, anti-smoking
actions have been a part of the Program for the reduction of health
consequences of tobacco smoking in Poland. This program was implemented in
accordance with the provisions of Article 4 of the previously mentioned Act on
health prevention against consequences of the use of tobacco and tobacco
products, which states that the Council of Ministers establishes a program
setting out health, social and economic policies aimed at reducing the use of
tobacco products, which should be financed by the state budget at the level of
0.5% of the excise tax on tobacco products. Due to the interpretation issues
regarding the financing of anti-smoking actions, while working on the Public
Health Act of September 11th, 2015 (Journal of Laws of 2015,
item 1916), this Article has been repealed. Since January 1st, 2018,
the activities relating to reducing exposure to tobacco smoke have been
included in the operational objective 2: Prevention of addiction, contained in
the Regulation of the Council of Ministers of March 30th, 2021 on
the National Health Program for years 2021 - 2025 (Journal of Laws item
642).
Results
The
legal basis for the operation of national campaigns is usually the regulations
of the Council of Ministers, which describe the objectives, scope, and expected
effects of a program in detail (e.g. the Regulation of the Council of Ministers
of March 30th 2021on the National Health
Program for years 2021 - 2025 [12], the Regulation of the Minister of
Health of November 6th, 2013 on
guaranteed services of health programs (Journal of Laws of 2020,
item 2209)[13]).
The
current prevention programs implement comprehensive health-promoting
activities, one of which is the reduction of tobacco consumption. This is
directly reflected in the financing of such activities.
In
the three studied programs, the proposed strategic objective of anti-smoking
prevention can be considered the same, namely, it is supporting the reduction
of tobacco product consumption, which is supposed to reduce the number of
tobacco-related disorders (particularly the incidence of tobacco-related
cancer).
The
authors of the National Health Program and the Prevention of tobacco-related
disorders program (including COPD) do not set a specific target for the
reduction of tobacco-related disorders by using general performance indicators
such as ‘reducing mortality in tobacco-related disorders’. The performance indicators are clearly
defined in the National Oncology Strategy, which sets specific targets, but the
methodology of their estimation remains unclear.
The target groups of the three studied programs were defined as
the general public over the age of 15. As part of the prevention of
tobacco-related disorders program (including COPD), the Regulation of the
Minister of Health of June 10th, 2022 amending the Regulation on
guaranteed services of health programs [14] was published on July 7th,
2022; one of the most important elements of this program is that the specialty
care level should be offered to patients over the age of 16 (until now the
program has only been dedicated to adults).
The proposed anti-smoking prevention actions are primarily aimed
at supporting the creation of the Clinics for Support of Smokers, as well as
organizing training for medical staff, covering so-called ‘rapid anti-smoking
interventions’.
The
detailed comparative analysis is presented in Table 2.
Discussion
Currently, anti-smoking
actions financed by the state budget are implemented as part of national health
programs, such as the National Health Program or the National Oncology
Strategy. The lack of one comprehensive anti-smoking program makes the proposed
actions redundant and focused primarily on creating Clinics for Support of
Smokers and training of medical staff to assist patients. Those actions are
most often carried out because they have proven effective. Even a short
intervention (< 3 minutes) given to a person addicted to tobacco affects the
rate of smoking reduction (OR = 1.66; 95% CI, 1.42 – 1.94) and is highly
cost-effective [15]. It is necessary to implement those actions because,
according to the information in the commentary to the previously mentioned amendment
to the Regulation on guaranteed services of health programs, there are currently ten anti-smoking
clinics nationwide representing the specialty care level in the anti-smoking
program. [16] Ensuring an adequate number of clinics is one of the most important
elements in the update of the Prevention of tobacco-related disorders program
(including COPD). The next step should be to ensure adequate funding for this
program. Allocating financial resources is necessary for the implementation of
Article 14 of the Framework Convention on Tobacco Control (FCTC) [17], to which
Poland is also a party [18], indicating the need to develop and implement
effective programs to encourage smoking cessation. Considering Article 26 of
the FCTC, each Party should provide financial support for its own national
efforts aimed at achieving the objective of the Convention, in accordance with
its national plans, priorities and programs.
There are many possible ways
to finance health programs by transferring the costs of their implementation to
industry and retail outlets selling tobacco products, for example by developing
appropriate taxation, licensing fees for tobacco production, import and sales,
implementing registration fees or introducing annual fees for control of tobacco
products [19].
The definition of a single comprehensive
anti-smoking program could improve the effectiveness of anti-smoking actions by
adapting their content to different target groups (e.g. appropriate for the
consumer’s age). The development of such programs would make it possible to
determine the amount of financial resources allocated to anti-smoking actions
alone, because currently the overall funding for all actions is determined for
each health program, which certainly makes it difficult to plan its
implementation.
In addition, there is currently no institution
that could fully coordinate anti-smoking activities carried out under a single
program through e.g. adequate funding and quality control of the developed
actions. According to the Polish experts in this field: a continued cooperation
between governmental institutions and NGOs, as well as adequately funded health
programs themselves, would make Poland one of the leading countries in terms of
tobacco control, and would significantly improve public health indicators [20].
Another challenge is to establish verifiable
performance indicators. Reducing the incidence of tobacco-related disorders is
an interdisciplinary challenge. Smoking cessation support consists of a number
of elements such as increasing tobacco prices, increasing excise tax, or
implementing provisions of directives governing the tobacco market. With this
in mind, it is difficult to identify the direct impact of a program on e.g.
achieving reduction in the rate of tobacco-related disorders. It is, therefore,
appropriate to keep the general performance indicators without providing any
specific values. Moreover, continuation of the current anti-smoking
intervention programs could reduce premature deaths (before age 65) by up to
half [21], which would allow Poland to catch up with public health leaders such
as Sweden.
Training of medical staff is
an important element of anti-smoking prevention; however, young people who
start using nicotine-based products acquire knowledge about the harmful effects
of smoking in their school environment. Therefore, educational activities
should be taken to promote anti-smoking attitudes among children and
adolescents. Young people are keen to participate in such education programs,
however, it is important to regularly update materials and adapt to the new
public health challenges such as electronic cigarettes and heated tobacco
products. It is estimated that about 28% of boys and 18.6% of girls aged 13 -
15 use e-cigarettes in Poland. Poland has one of the highest rates of
e-cigarette use among teenagers [22].
Moreover, since 2019, we have
seen an increase in the percentage of users of heated tobacco products (from
0.4% to 4%); interestingly, the rate of daily heated tobacco consumption almost
tripled in the economically active population [23].
As smoking initiation starts
at school age, promoting the reduction of tobacco use, including heated tobacco
products and electronic cigarettes, should be prioritized in this target group,
accompanied by adapting education campaigns to specific disorders caused by
tobacco smoking.
Gender, age, and smoking are
indeed correlated with the level of awareness of smoking-related disorders, and
it is, therefore, also important to implement educational campaigns that
clearly point out the health effects of tobacco use (especially non-respiratory
diseases), adapted to different disease groups [24]. The available data suggest
that up to 50% of patients who smoked before the diagnosis of cancer still
smoke during treatment, unaware of the harm associated with continued tobacco
use, and the underestimated benefits of smoking cessation after the diagnosis
of cancer; such benefits include reduced risk of death by 30% up to 40% [25].
Our study has practical implications
for actions undertaken as part of health programs aimed at reducing tobacco
smoking. First of all, it pointed out the need to establish a single
comprehensive anti-smoking program, which is guaranteed to limit double funding
of the same activities carried out in different preventive programs.
Furthermore, it was pointed out that there is currently no single coordinating
institution in Poland for anti-smoking prevention and that there is no
education on tobacco-related disorders adapted to different target groups.
The limitations of our study should
also be mentioned. Only three national programs have been selected for the
analysis; at the same time, the role of local authorities should be emphasized,
which have their own public funds dedicated to the implementation of local
prevention activities. It is the local authorities that are largely responsible
for developing appropriate health programs for disease prevention and health
promotion, including activities aimed at reducing tobacco smoking.
Conclusions
At the national level, there
is currently no single comprehensive program to limit the use of nicotine
products. Such activities are currently one of the elements of many health
programs targeted toward the general public. Therefore, some actions are the
same in different programs (including the promotion of anti-smoking counseling
and medical staff training).
To effectively reduce smoking,
it is necessary to develop a single comprehensive program with adequate
funding. It should take into account different target groups and it should be
coordinated by one of the agencies subordinate to the Minister of Health.
It is also important that the developed performance indicators are achievable; also, it is important to be aware that reducing the incidence of tobacco-related disorders is an activity that is influenced by various components, which indicates its interdisciplinary nature.
Charts and Figures
Table I. National health prevention programs were identified coordinated by the Ministry of Health relating to tobacco use reduction.
DISEASE |
PROGRAM |
DESCRIPTION |
LINK |
STROKE |
The Polish National Cerebrovascular Disease
Prevention Program (ICD10: I60-I69) |
Prevention
and early diagnosis of cerebrovascular disorders, including stroke and
transient ischemic attacks (TIA) in middle-aged individuals (aged 40 - 65) at
the time and place of program operation |
https://www.gov.pl/web/zdrowie/profilaktyka-chorob-naczyn-mozgowych |
COPD |
Prevention of chronic obstructive pulmonary
disease: 'Take a deep breath' |
The main
goal of the program is to raise society's awareness about chronic obstructive
pulmonary disease, reduce morbidity and premature mortality due to pulmonary
disorders, and minimize the health risk associated with tobacco smoking. |
https://pacjent.gov.pl/programy-profilaktyczne/wiem-wiecej-o-pochp |
COPD |
Prevention of tobacco-related disorders
program (including COPD) |
The goal
is to reduce the morbidity of tobacco-related disorders, reduce COPD-related morbidity, disability, and
mortality through complex educational and therapeutic interventions among
high-risk groups, together with early detection of COPD and other tobacco-related
disorders, and improve access to therapy for smoking addiction and lung
disorders. |
https://pacjent.gov.pl/program-profilaktyczny/program-profilaktyki-chorob-odtytoniowych |
COPD |
The National
Program for Mortality Reduction in Chronic Lung Disorders by Creation of
Non-Invasive Mechanical Ventilation Units (NiMV) |
The aim of
this health policy program is to reduce mortality in chronic lung disorders
in the Republic of Poland by: organizing 220 (NiMV) units in the lung disease
departments equipped with devices crucial for conducting and monitoring NiMV,
increasing access to NiMV, controlling and monitoring the effectiveness of
the program. |
|
HEART
ATTACK |
Cardiovascular
disease (CVD) prevention |
The aim of
this program is to reduce morbidity and mortality by about 20% in cardiovascular
diseases covered by the program by early detection and reduction of frequency
and severity of risk factors, increasing detection and therapeutic efficacy
in cardiovascular diseases (CVD), early identification of individuals with an
increased risk of CVD, promoting healthy lifestyle and smoking cessation,
healthy diet, and physical activity. |
https://pacjent.gov.pl/programy-profilaktyczne/program-profilaktyki-chorob-ukladu-krazenia-chuk |
HEART
ATTACK |
Prevention of
cardiovascular diseases (KORDIAN) |
The main
goal of this program is to raise awareness and improve the detection of
cardiovascular diseases in economically active individuals, including
identification of patients with hereditary familial hypercholesterolemia (FH)
at the time and place covered by the program. |
https://pacjent.gov.pl/programy-profilaktyczne/program-profilaktyki-chorob-kardiologicznych |
HEART
ATTACK |
Prevention and Treatment of Cardiovascular
Diseases Program POLKARD |
The main
goal is to equip hospitals with medical devices as well as to: - keep
medical registers to evaluate treatment efficacy, - increase
access to novel therapies, care, and modern screening programs. |
|
HEART
ATTACK |
40 PLUS program |
The main
goal of the '40 PLUS' program is to assess the organization and efficacy of
screening in patients aged above 40 regarding the most common health
problems. It should be noted that due to the coronavirus pandemic,
prophylaxis has been negatively affected, i.e. fewer patients presented to
their physician in 2020. Many disorders, especially at an early stage, do not
produce worrying symptoms. Thanks to screening programs, it is possible to
detect a disease early on and prevent long-term or even ineffective treatment
as a result of delayed diagnosis. |
https://www.gov.pl/web/zdrowie/profilaktyka-40-plus
|
LUNG
CANCER |
The Polish National Program for Early
Detection of Lung Cancer (EDLC) by low-dose computed tomography (LDCT) |
The goal
of this health policy program is to improve the early detection of lung
cancer by providing appropriate prophylaxis for a selected population of
Polish residents. |
https://pacjent.gov.pl/programy-profilaktyczne/profilaktyka-raka-pluca |
LUNG
CANCER |
The National Oncology Strategy (NOS) |
Action 3
of NOS: Raising awareness
among adults about the impact of a healthy lifestyle on cancer Increasing
the extend of social campaigns by 50% by standardizing and intensifying
educational activities promoting a healthy lifestyle, including: - promotion
of physical activity and healthy diet, - promotion of a tobacco-free
lifestyle, - raising awareness about the risks of UV radiation. Activity
17 of NOS: Implementation
of complex and coordinated oncology care in Poland. New organizational model
for patient care ("Cancer Units") for key cancers: lung,
colorectal, gynecologic and urologic cancers. |
https://www.gov.pl/web/zdrowie/narodowa-strategia-onkologiczna-nso |
TYPE
2 DIABETES |
The National Health Program (NHP) |
Task V.4
of NHP: Education
directed towards diabetic patients and their families or caregivers to reduce
diabetes-related complications and to improve the quality and length of their
lives. |
https://www.gov.pl/web/zdrowie/narodowa-strategia-onkologiczna-nso |
TYPE
2 DIABETES |
The support program for outpatient management
of the diabetic foot syndrome |
As a part of the
program, it is intended to equip the diabetic foot syndrome centers, which
play two roles: - a reference role,
i.e. they operate as an outpatient unit of a hospital diabetology department
as coordinators in the voivodeship, - a primary role,
i.e. they operate at ambulatory diabetology care centers. |
https://www.gov.pl/web/zdrowie/program-wsparcia-ambulatoryjnego-leczenia-zespolu-stopy-cukrzycowej |
Table II. Comparative analysis of programs which covered anti-smoking actions as one of their main objectives.
PROGRAM
NAME |
||
The Prevention of tobacco-related disorders
program (including COPD) |
The National Oncology Strategy |
The National Health Fund |
LEGAL
BASIS |
||
The
Regulation of the Minister of Health of November 6th, 2013 on the guaranteed
services of health prevention programs (Journal of Laws of 2020, item
2209). |
The
Resolution of the Council of Ministers of February 4th, 2020 (M.P.
[Official Journal of the Republic of Poland (Monitor Polski)], item 189) on
the adoption of the long-term 'National Oncology Strategy' Program for the
years 2020 - 2030 |
The
Regulation of the Council of Ministers of March 30th, 2021 on the
National Health Program for the years 2021 - 2025 |
PROGRAM
PROVIDERS REGARDING TOBACCO |
||
The National Health Fund
|
The
Ministry of Health, the National Research Institute of Oncology (Narodowy
Instytut Onkologii - Państwowy Instytut Badawczy, NIO-PIB) |
Providers indicated individually for each
task
|
FINANCING |
||
Primary care stage: 114,000
PLN (2021)
Specialty
care stage: 58,000 PLN
(2021) |
In the
given years, all planned government spending on all activities of the NOS
cannot exceed: ▪ in 2020
– 250M PLN, ▪ between
2021 and 2023 – 450M PLN annually, ▪ between
2024 and 2030 – 500M PLN annually. |
The
financing from the Gambling Problem Fund and the state budget for a goal/task
called: addiction prevention (including nicotine addiction) - no more than
30M PLN. |
STRATEGIC
GOALS REGARDING TOBACCO |
||
In order
to gradually reduce the number of smokers, it is necessary to undertake
multidirectional actions, and hence one of the most important health interventions
is the treatment of nicotine addiction.
|
Investments
in education, primary prophylaxis, and lifestyle Reducing
cancer incidence by limiting risk in terms of primary cancer prevention. The
actions are aimed at implementing the European Code Against Cancer
recommendations including reducing tobacco smoking as well as involving
physicians, particularly general practitioners (GP) and occupational medicine
physicians, in primary prophylaxis. |
The
strategic goal of the National Health Program for the years 2021 - 2025,
referred to hereinafter as NHP, is to increase the number of healthy years
and to reduce social inequalities in health. |
PERFORMANCE
INDICATORS |
||
The
greatest demand for the program has been identified for the following
voivodeships: Masovian (76k), Silesian (65k), Greater Poland (50k), Lesser
Poland (49k), and Lower Silesian (42l). Assuming that one in four adult Poles
trying to quit smoking will decide to participate in the program, resources
for 274,000 people should be allocated; however, if 75 out of 100 people
trying to quit smoking decided to take part in the program, the number of
individuals would rise up to 823,000. |
●
Mortality rate (per 100,000) for colorectal cancer (ICD10: C18–C21, ESP2013): Values observed in
2017: 52.9 in males; 26.4
in females Target values for
2025:* 49.3 in males; 22.4
in females ● Mortality rate (per 100,000) for breast cancer in females (ICD10: C50, ESP2013) Value observed in
2017: 32.7 The target value for
2025: 27.8 ●
Mortality rate (100,000) for cervical cancer (ICD10: C53, ESP2013) Value observed in
2017: 7.9 The target value for
2025: 4.9 ●
Mortality rate (per 100,000) for skin melanoma (ICD10: C43, ESP2013) Values observed in
2017: 5.3 in males; 3.5 in
females Target values for
2025: 6.8 in males; 4.0 in
females ●
Mortality rate (per 100,000) for lung cancer: Values observed in
2017: 108.3 in males; 38.3
in females Target values for
2025: 78.5 in males; 38.9
in females By the end of 2030,
Poland will increase the number of girls and boys aged below 15 declaring that
they do not consume tobacco products - from 87.5% and 88.2%, respectively, up
to 92%. By the end of 2030, Poland will reduce the number of females and males consuming tobacco products -
from 18% and 24% down to 15% and 20%, respectively. |
Reducing
mortality for lung cancer and reducing the number of regular smokers
(including children and adolescents) in Poland. |
TARGET
GROUPS |
||
Primary
level: Individuals
aged 18 or above consuming tobacco or novel tobacco products or electronic
cigarettes. Specialty
level: Individuals
aged 16 or above addicted to tobacco, including novel
tobacco products (ICD-10: F17), or addicted to electronic cigarettes,
referred from the primary level or from the hospital, or presenting without
referral. |
Males and
females aged 15 or above. |
Conducting
medical staff training in the management of nicotine addiction, and running
the Telephone Clinics for Support of Smokers (by NIO-PIB based on the contract
with the Ministry of Health upon the request of NIO-PIB) Facilitating
smoking cessation, including novel tobacco products and electronic
cigarettes, by providing access to specialty care for the whole nation. |
ACTIONS |
||
Anti-nicotine
counseling Considering
the earlier points and in order to help reduce consumption of all
nicotine-containing products, the program has been supplemented by supporting
to quit novel tobacco products and electronic cigarettes. |
Until
2023, there will be Clinics for
Support of Smokers in each voivodeship, to coordinate educational
actions in terms of anti-smoking prevention as part of the National Network
for Supporting Smokers. Until the end od 2021, the prevention of tobacco-related disorders program will be modified (including COPD) and will be adapted to the challenges stated in the map of health needs. Until
2024, the process of medical staff training (hospital,
primary care, and occupational medicine) in terms of primary prophylaxis,
particularly regarding the management of tobacco addiction Until the end of 2030 no less than 50,000 medical staff in Poland will be familiarize with the recommendations of the European Code Against Cancer. |
Implementing medical staff training in management of nicotine addiction and running the Telephone Clinic for Support of Smokers Facilitating
smoking cessation, including novel tobacco products and electronic cigarettes,
by providing access to specialty care. Reducing
physical and economic availability of tobacco and other related products. Promoting
international cooperation on policy to reduce health consequences of tobacco
use, including novel tobacco products, electronic cigarettes, and refill
fluids. |
1.
World Health Organization (WHO):
Tobacco. Available from: https://www.who.int/health-topics/tobacco#tab=tab_1
2.
Special Eurobarometer 506 Report
“Attitudes of Europeans towards tobacco and electronic cigarettes”, European
Union, 2021;
https://europa.eu/eurobarometer/surveys/detail/2240
3.
WHO report on the global tobacco
epidemic 2021: addressing new and emerging products. Geneva: World Health
Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO;
https://www.who.int/publications/i/item/9789240032095
4. Konsumpcja nikotyny raport z badań ilościowych dla Biura do Spraw
Substancji Chemicznych Edycja III, Centrum Badania Opinii Społecznej, Warszawa
listopad 2020;
https://www.gov.pl/web/chemikalia/monitorowanie-rynku-e-papierosow
5. Ustawa z dnia 9 listopada 1995 r. o ochronie zdrowia przed następstwami
używania tytoniu i wyrobów tytoniowych (Dz. U. z 2021 r. poz. 276);
https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU19960100055/U/D19960055Lj.pdf
6. Ustawa z dnia 11 września 2015 r. o zdrowiu publicznym (DZ. U. z 2021 r.
poz 1956, 2469); https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20150001916/U/D20151916Lj.pdf
7. https://pacjent.gov.pl/programy-profilaktyczne/wiem-wiecej-o-pochp
8.
https://www.gov.pl/web/zdrowie/profilaktyka-chorob-naczyn-mozgowych
10.
https://www.gov.pl/web/zdrowie/narodowa-strategia-onkologiczna;
11. Uchwała nr 10 Rady Ministrów z dnia
4 lutego 2020 r. w sprawie przyjęcia programu wieloletniego pn. Narodowa Strategia
Onkologiczna na lata 2020-2030;
https://isap.sejm.gov.pl/isap.nsf/download.xsp/WMP20200000189/O/M20200189.pdf
12. Rozporządzenie Rady Ministrów z dnia
30 marca 2021 r. w sprawie Narodowego Programu Zdrowia na lata 2021-2025;
https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20210000642/O/D20210642.pdf
13. Obwieszczenie Ministra Zdrowia z
dnia 10 listopada 2020 r. w sprawie ogłoszenia jednolitego tekstu
rozporządzenia Ministra Zdrowia w sprawie świadczeń gwarantowanych z zakresu
programów zdrowotnych;
https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20200002209/O/D20202209.pdf
14. Rozporządzenie Ministra Zdrowia z
dnia 10 czerwca 2022 r. zmieniające rozporządzenie w sprawie świadczeń
gwarantowanych z zakresu programów zdrowotnych (Dz. U. z 2022 r. poz. 1433);
https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20220001433/O/D20221433.pdf
15.
U.S. Department of Health and
Human Services. Smoking
Cessation. A Report of the Surgeon General. Atlanta,
GA: U.S. Department of Health and Human Services, Centers for Disease Control
and Prevention, National Center for Chronic Disease Prevention and Health
Promotion, Office on Smoking and Health, 2020 [accessed 2020 May 21];
16. https://legislacja.rcl.gov.pl/projekt/12355501/katalog/12847785#12847785;
17.
WHO
Framework Convention on Tobacco Control, WHO Document WHA56.1; https://apps.who.int/gb/archive/pdf_files/WHA56/ea56r1.pdf;
18. Oświadczenie Rządowe z dnia 16 stycznia 2007 r. w sprawie mocy
obowiązującej Ramowej Konwencji Światowej Organizacji Zdrowia o Ograniczeniu
Użycia Tytoniu, sporządzonej w Genewie dnia 21 maja 2003 r. (Dz. U. z
2007 r. Nr 74 poz. 488);
https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20070740488/O/D20070488.pdf
19.
WHO Framework Convention on
Tobacco Control: guidelines for implementation Article 5.3; Article 8; Articles
9 and 10; Article 11; Article 12; Article 13; Article 14 – 2013 edition;
https://apps.who.int/iris/handle/10665/80510
20.
Jassem
J, Przewoźniak K, Zatoński W. Tobacco control in Poland-successes and
challenges. Transl Lung Cancer Res. 2014 Oct;3(5):280-5. :
10.3978/j.issn.2218-6751.2014.09.12. PMID: 25806312; PMCID: PMC4367772
21.
Witold A. Zatoński; Mateusz Zatoński; Kinga Janik-Koncewicz;
Katarzyna Połtyn-Zaradna; Katarzyna Wijatkowska; Arlen Marciniak Hundred years of cigarette smoking in Poland: three phases of the
tobacco epidemic. Journal of Health
Inequalities, ISSN: 2450-5927, Vol: 3, Issue: 2, Page: 118-122 doi:10.5114/jhi.2017.74200
22.
Jankowski
M, Ostrowska A, Sierpiński R, Skowron A, Sytnik-Czetwertyński J, Giermaziak W,
Gujski M, Wierzba W, Pinkas J. The Prevalence of Tobacco, Heated Tobacco, and
E-Cigarette Use in Poland: A 2022 Web-Based Cross-Sectional Survey. Int J
Environ Res Public Health. 2022 Apr 18;19(8):4904. https//doi:
10.3390/ijerph19084904. PMID: 35457771; PMCID: PMC9031359.
23.
Szymański,
J.; Ostrowska, A.; Pinkas, J.; Giermaziak, W.; Krzych-Fałta, E.; Jankowski, M.
Awareness of Tobacco-Related Diseases among Adults in Poland: A 2022 Nationwide
Cross-Sectional Survey. Int.
J. Environ. Res. Public Health 2022, 19, 5702. doi.org/10.3390/ijerph19095702
24.
Koczkodaj P, Didkowska J, Balwicki
Ł, Cedzyńska M, Dominiak M, Hanke W, Jankowski P, Jassem J, Juszczyk G,
Krzakowski M, Pinkas J, Przepiórka I, Przewoźniak K, Rutkowski P, Śliż D,
Wesołowski S, Zdrojewski T, Walewski J. World Tobacco Quitting Day 2020 – the
united voice of Polish experts on tobacco prevention and control. NOWOTWORY J Oncol 2020; 70: 278–279.
25.
Koczkodaj, P., Cedzyńska,
M., Rutkowski, P., Janiak, A., Przepiórka, I., Ciuba,
A., Mańczuk, M., Przewoźniak, K., Didkowska, J. (2021). Smoking cessation
help for cancer patients – a pilot project “Quitting Supports Treatment”. Nowotwory Journal of Oncology, 3,
176-178. doi: 10.5603/NJO.2021.0033